Jefferies Starts Coverage on Engene, Assigns Buy and $28 Target
Jefferies has launched coverage of Engene Holdings Inc. (ENGN) with a Buy rating and a $28 price target, implying roughly 173% upside from the stock's current level of $10.27. The firm highlights Engene's ongoing pivotal study in high-risk non-muscle invasive bladder cancer (HR-NMIBC), a key data update expected in the second half of 2026, and favo…